** Shares of Max Healthcare Institute MAXE.NS slip 2.1% to 1,018.7 rupees, biggest loser on blue-chip Nifty 50 index .NSEI
** Hospital chain posted a 26% jump in Q3 profit, rev grew 10.7%, supported by growth in international and outpatient consultations
** However, ICICI Direct highlights moderation in earnings growth as capacity utilisation increases
** Q3 rev growth slowest in 14 quarters, profit growth hits one-year low - data compiled by LSEG
** MAXE's bed utilisation rate at 74% in Q3 vs 67% year ago
** Analysts tracking MAXE rate it "hold" on average, same as peers - LSEG data
** Stock fell 8.5% in January vs Nifty 50's 3.1% drop
(Reporting by Nandan Mandayam in Bengaluru)
((Nandan.Mandayam@thomsonreuters.com; Mobile: +91 9591011727;))